COVID-19

Posts and information on COVID-19 for Meakins-Christie, RECRU, and RESP members.

Ciclesonide Clinical Trial for COVID-19

Drs. Nicole Ezer, James Martin, Ben Smith, Andrea Benedetti and colleagues initiate ciclesonide clinical trial for COVID-19

Dr. Dick Menzies and colleagues publish a new cost-analysis study that recommends systematic SARS-CoV-2 testing in priority groups

Dr. Irah King discusses disease tolerance in light of the recent COVID-19 pandemic and why some weather the infection unscathed

Dr. Jean Bourbeau is leading a new Phase III clinical trial with dapson to target lung inflammation caused by COVID-19

Dr. Peter Goldberg receives an Innovation grant to build a clinical-grade ventilator that can be produced cheaply and easily

Dr. Goldberg in La Presse – COVID-19 patients’ experiences post-ICU: enduring side effects and a long recovery.

Dr. Carolyn Baglole received a CIHR catalyst grant from the recent Health Effects of Vaping competition

Dr. Maziar Divangahi asserts that only a team effort across scientific disciplines will lead to the elimination of SARS-CoV-2.

Thanks to Adomo Donovan and the ICU Bridge Program, the MUHC’s ICU staff are now recognizable despite their PPE.

A new clinical trial, designed by Drs. Ezer, Martin, Benedetti & Smith, will test ciclesonide in the early stages of COVID-19.